类风湿关节炎患者与匹配对照相比的泌尿系统癌症风险:一项全国性队列研究
该回顾性队列研究利用韩国国民健康保险系统数据库(2010—2020年),纳入类风湿关节炎(RA)患者并按1:5匹配非RA人群,分析RA与肾癌、膀胱癌、前列腺癌及睾丸癌风险的关系及血清学状态的影响。结果显示RA患者肾癌风险升高(aHR 1.34,95%CI 1.04-1.78),女性RA患者更高(aHR 1.57,95%CI 1.10-2.24),而膀胱癌、前列腺癌、睾丸癌风险与RA无关,血清学状态间无显著差异。
要点
- RA患者肾癌风险较非RA人群升高(aHR 1.34,95%CI 1.04-1.78)。
- 女性RA患者肾癌风险更高(aHR 1.57,95%CI 1.10-2.24)。
- 膀胱癌、前列腺癌、睾丸癌风险与RA无关,血清学状态间无显著差异。
核心结论
- RA患者肾癌风险高于一般人群,需进一步研究以理解RA与肾癌关联的机制,从而优化癌症预防和筛查策略。
研究设计与样本
- 该研究为回顾性队列研究,使用韩国国民健康保险系统数据库(2010—2020年)数据,纳入RA患者及按1:5匹配的非RA人群,RA患者按血清学状态分组,采用Cox比例风险回归分析校正潜在混杂因素。
主要发现
- RA患者肾癌风险较非RA人群升高(aHR 1.34,95%CI 1.04-1.78)。
- 女性RA患者肾癌风险更高(aHR 1.57,95%CI 1.10-2.24)。
- 膀胱癌风险与RA无关(aHR 1.24,95%CI 0.95-1.62)。
- 前列腺癌风险与RA无关(aHR 1.13,95%CI 0.94-1.35)。
- 睾丸癌风险与RA无关(aHR 2.31,95%CI 0.44-12.20)。
关键数值与推荐
- 主要结局为新诊断泌尿系统癌症,RA与泌尿系统癌症的关联采用Cox比例风险回归分析校正潜在混杂因素。
- 按血清学状态分组比较,未发现泌尿系统癌症风险有显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出需进一步研究以理解RA与肾癌关联的机制,从而优化癌症预防和筛查策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with several comorbidities, including an increased risk of certain cancers. This study aimed to investigate the potential associations between RA and increased risk of urological cancers - specifically kidney, bladder, prostate and testicular cancers - and the influence of RA serological status on this risk. METHODS: This retrospective cohort study used data from the Korean National Health Insurance System database (2010-2020), including patients with RA and a 1:5 matched non-RA population. RA patients were grouped according to serological status. The primary outcome was newly diagnosed urological cancer, and its association with RA was analysed by Cox proportional hazards regression analyses adjusting for potential confounders. RESULTS: RA patients had an increased risk of kidney cancer compared with the non-RA population {adjusted hazard ratio (aHR), 1.34 [95% confidence interval (CI), 1.04-1.78]}. The risk of kidney cancer was even higher in women with RA [aHR 1.57 (95% CI: 1.10, 2.24)]. However, the risk of bladder, prostate and testicular cancers was not associated with RA (bladder cancer, aHR 1.24, 95% CI 0.95-1.62; prostate cancer, aHR 1.13, 95% CI 0.94-1.35; testicular cancer, aHR 2.31, 95% CI 0.44-12.20). No significant difference in urological cancer risk was found according to serological status. CONCLUSIONS: RA patients have a higher risk of kidney cancer than the general population. Further research is needed to understand the mechanisms underlying the association between RA and kidney cancer to optimize cancer prevention and screening strategies.
引用
- Lee D, Jeon KH, Jung J, et al. Urological cancer risk in patients with rheumatoid arthritis compared to matched controls: a nationwide cohort study. Rheumatology (Oxford). 2025. PMID: 39951303. doi:10.1093/rheumatology/keaf103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。